Research Analysts’ Recent Ratings Updates for Oscar Health (OSCR)

Several analysts have recently updated their ratings and price targets for Oscar Health (NYSE: OSCR):

• 8/13/2026 – Oscar Health had its price target raised by Wells Fargo & Company from $20.00 to $27.00. They now have an “equal weight” rating on the stock.
• 8/12/2026 – Oscar Health had its “mixed” rating reaffirmed by Wells Fargo & Company.
• 8/11/2026 – Oscar Health had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $30.00 price target on the stock.
• 8/11/2026 – Oscar Health was upgraded by Weiss Ratings from “sell (d+)” to “hold (c+)”.
• 8/7/2026 – Oscar Health was given a new $27.00 price target by Robert W. Baird.
• 8/7/2026 – Oscar Health had its price target raised by UBS Group AG from $20.00 to $26.00. They now have a “neutral” rating on the stock.
• 8/6/2026 – Oscar Health had its price target raised by Barclays PLC from $35.00 to $39.00. They now have an “overweight” rating on the stock.
• 7/28/2026 – Oscar Health had its “overweight” rating reaffirmed by Piper Sandler. They now have a $36.00 price target on the stock.
• 7/10/2026 – Oscar Health was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
• 7/6/2026 – Oscar Health was upgraded by Zacks Research from “hold” to “strong-buy”.
• 6/24/2026 – Oscar Health was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.

Insider Activity

In other Oscar Health news, insider Janet Liang sold 12,475 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the completion of the transaction, the insider owned 259,057 shares in the company, valued at $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam Mcananey sold 9,859 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the transaction, the insider directly owned 218,096 shares in the company, valued at approximately $4,785,026.24. The trade was a 4.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 3,562,466 shares of company stock worth $102,829,815 over the last three months. Company insiders own 22.64% of the company’s stock.

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.